
Brian J. Gangle
Examiner (ID: 511, Phone: (571)272-1181 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1233 |
| Issued Applications | 798 |
| Pending Applications | 132 |
| Abandoned Applications | 327 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15454563
[patent_doc_number] => 20200040106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => HYBRIDOMA CELL LINE OF SECRETING MELOXICAM MONOCLONAL ANTIBODIES AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/222377
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16222377
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/222377 | Hybridoma cell line of secreting meloxicam monoclonal antibodies and application thereof | Dec 16, 2018 | Issued |
Array
(
[id] => 14454295
[patent_doc_number] => 10323100
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-06-18
[patent_title] => Hybridoma cell line of secreting clarithromycin monoclonal antibodies and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 16/222792
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3535
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16222792
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/222792 | Hybridoma cell line of secreting clarithromycin monoclonal antibodies and preparation method thereof | Dec 16, 2018 | Issued |
Array
(
[id] => 15913107
[patent_doc_number] => 10653775
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Anti-glucosaminidase passive immunization for
[patent_app_type] => utility
[patent_app_number] => 16/221442
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 42
[patent_no_of_words] => 20515
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16221442
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/221442 | Anti-glucosaminidase passive immunization for | Dec 13, 2018 | Issued |
Array
(
[id] => 16523755
[patent_doc_number] => 20200397835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => Methods of Treating Dog Urinary Tract Infections
[patent_app_type] => utility
[patent_app_number] => 16/769962
[patent_app_country] => US
[patent_app_date] => 2018-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16769962
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/769962 | Methods of treating dog urinary tract infections | Dec 3, 2018 | Issued |
Array
(
[id] => 16397281
[patent_doc_number] => 20200338139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => COMPOSITIONS FOR MICROBIAL ANTI-ADHESION
[patent_app_type] => utility
[patent_app_number] => 16/765372
[patent_app_country] => US
[patent_app_date] => 2018-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16765372
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/765372 | COMPOSITIONS FOR MICROBIAL ANTI-ADHESION | Dec 3, 2018 | Abandoned |
Array
(
[id] => 18590465
[patent_doc_number] => 11739349
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Primate retinal pigment epithelium cell-specific promoter
[patent_app_type] => utility
[patent_app_number] => 16/764306
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10642
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16764306
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/764306 | Primate retinal pigment epithelium cell-specific promoter | Nov 14, 2018 | Issued |
Array
(
[id] => 14156599
[patent_doc_number] => 20190105402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => ExPEC GLYCOCONJUGATE VACCINE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/191659
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16191659
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/191659 | ExPEC glycoconjugate vaccine formulations | Nov 14, 2018 | Issued |
Array
(
[id] => 16786354
[patent_doc_number] => 10988769
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Paenibacillus-based endospore display platform, products and methods
[patent_app_type] => utility
[patent_app_number] => 16/191964
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26157
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16191964
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/191964 | Paenibacillus-based endospore display platform, products and methods | Nov 14, 2018 | Issued |
Array
(
[id] => 13983423
[patent_doc_number] => 20190060869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => CHROMATOGRAPHY LIGAND COMPRISING DOMAIN C FROM STAPHYLOCOCCUS AUREUS PROTEIN A FOR ANTIBODY ISOLATION
[patent_app_type] => utility
[patent_app_number] => 16/189894
[patent_app_country] => US
[patent_app_date] => 2018-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16189894
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/189894 | Chromatography ligand comprising domain C from | Nov 12, 2018 | Issued |
Array
(
[id] => 15358019
[patent_doc_number] => 10527621
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Antibody to cytolethal distending toxin of Campylobacter jejuni
[patent_app_type] => utility
[patent_app_number] => 16/185955
[patent_app_country] => US
[patent_app_date] => 2018-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11409
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16185955
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/185955 | Antibody to cytolethal distending toxin of Campylobacter jejuni | Nov 8, 2018 | Issued |
Array
(
[id] => 14497983
[patent_doc_number] => 20190192646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => SALMONELLA VACCINES
[patent_app_type] => utility
[patent_app_number] => 16/180076
[patent_app_country] => US
[patent_app_date] => 2018-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16180076
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/180076 | SALMONELLA VACCINES | Nov 4, 2018 | Abandoned |
Array
(
[id] => 16341671
[patent_doc_number] => 20200306321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => ANTIMYCOTOXIN COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/759056
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16759056
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/759056 | Antimycotoxin composition | Oct 30, 2018 | Issued |
Array
(
[id] => 18869797
[patent_doc_number] => 11857577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Compositions and methods for the treatment of hepatic diseases and disorders
[patent_app_type] => utility
[patent_app_number] => 16/172825
[patent_app_country] => US
[patent_app_date] => 2018-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21411
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16172825
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/172825 | Compositions and methods for the treatment of hepatic diseases and disorders | Oct 27, 2018 | Issued |
Array
(
[id] => 17602881
[patent_doc_number] => 11331350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Use of
[patent_app_type] => utility
[patent_app_number] => 16/761933
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 9913
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761933
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/761933 | Use of | Oct 25, 2018 | Issued |
Array
(
[id] => 13926153
[patent_doc_number] => 20190046592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
[patent_app_type] => utility
[patent_app_number] => 16/171558
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16171558
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/171558 | Composition for inducing proliferation or accumulation of regulatory T cells | Oct 25, 2018 | Issued |
Array
(
[id] => 14210743
[patent_doc_number] => 20190117756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => Immunogenic Compositions and Vaccines Derived From Bacterial Surface Receptor Proteins
[patent_app_type] => utility
[patent_app_number] => 16/170420
[patent_app_country] => US
[patent_app_date] => 2018-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16170420
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/170420 | Immunogenic Compositions and Vaccines Derived From Bacterial Surface Receptor Proteins | Oct 24, 2018 | Abandoned |
Array
(
[id] => 17329209
[patent_doc_number] => 11219650
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-11
[patent_title] => Agent for preventing or treating small intestinal injury induced by specific NSAID and PPI
[patent_app_type] => utility
[patent_app_number] => 16/759683
[patent_app_country] => US
[patent_app_date] => 2018-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 19
[patent_no_of_words] => 12425
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16759683
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/759683 | Agent for preventing or treating small intestinal injury induced by specific NSAID and PPI | Oct 21, 2018 | Issued |
Array
(
[id] => 14420159
[patent_doc_number] => 10314866
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Method of reducing the likelihood of skin cancer in an individual human being
[patent_app_type] => utility
[patent_app_number] => 16/160336
[patent_app_country] => US
[patent_app_date] => 2018-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19136
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16160336
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/160336 | Method of reducing the likelihood of skin cancer in an individual human being | Oct 14, 2018 | Issued |
Array
(
[id] => 14808435
[patent_doc_number] => 20190270827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => PASSIVE IMMUNIZATION FOR STAPHYLOCOCCUS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/160880
[patent_app_country] => US
[patent_app_date] => 2018-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16160880
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/160880 | Passive immunization for | Oct 14, 2018 | Issued |
Array
(
[id] => 16908976
[patent_doc_number] => 11041003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-22
[patent_title] => Crystal structure of
[patent_app_type] => utility
[patent_app_number] => 16/160625
[patent_app_country] => US
[patent_app_date] => 2018-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 13276
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16160625
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/160625 | Crystal structure of | Oct 14, 2018 | Issued |